ARCHIVES

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

This article is from The Cancer Letter archive.

Vol. 40 No. 22 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Steven Curley Named Chief of Surgical Oncology At Baylor’s Dan L. Duncan Cancer Center

October 4, 2013

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Funding Opportunities: Lymphoma Fellowship

June 8, 2001

ONF Invites Applications for Fatigue Research

April 19, 1996

Regular NSAIDs Use Protects Smokers From Lung Cancer

March 28, 2003

ACS Ask Stronger Federal Action Against Cigarettes

November 23, 1979